Analysts’ updated EPS estimates for Tuesday, May 24:

Absci (NASDAQ:ABSI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapies. The Company’s Creation(TM) platform is involved in the discovery of new biotherapeutic drug candidates and the generation of cell lines to manufacture them in one efficient process. Absci Corporation is based in VANCOUVER, Wash. “

Air Liquide (OTCMKTS:AQUY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Air Liquide’s core business is to supply oxygen, nitrogen, hydrogen and many other gases and services to most industries (for example: steelmaking, oil refining , chemicals, glass, electronics, health, food, metallurgy, paper and aerospace). Their global presence (130 subsidiaries in more than 65 countries) allows them to combine the resources and expertise of a global company with a powerful local presence based on independent customer-centric teams. “

Lit (NYSE: ALIT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Alight Inc. is a cloud-based provider of integrated digital human capital and enterprise solutions. Alight Inc., formerly known as Foley Trasimene Acquisition Corp., is based in LAS VEGAS.”

ANTA Sports Products (OTCMKTS: ANPDF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ANTA Sports Products Limited designs, develops, manufactures, markets, distributes and markets sportswear in the People’s Republic of China. The Company’s products include footwear, apparel and accessories for professionals and consumers. ANTA Sports Products Limited is headquartered in Jinjiang City, People’s Republic of China. “

Applied Therapeutics (NASDAQ:APLT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have a target price of $1.75 on the stock. According to Zacks, “Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in the development of drug candidates for unmet medical needs. The Company’s product candidate consists of AT-001, for the treatment of diabetic cardiomyopathy; AT-007, for the treatment of galactosemia and AT-003, for the treatment of diabetic retinopathy which are in the clinical stage. Applied Therapeutics Inc. is based in New York, USA. “

Atlanta (OTCMKTS: ATASY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Atlantia SpA is a holding company responsible for portfolio strategies in the transportation and communications infrastructure and network sectors. The company builds and operates toll motorways in Italy and abroad. Atlantica is based in Rome, Italy. “

BigBear.ai (NYSE: BBAI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “BigBear.ai is a provider of artificial intelligence, machine learning, cloud-based big data analytics, and cyber engineering solutions. BigBear.ai, formerly known as GigCapital4 Inc ., is based in COLUMBIA, Md.”

Burning Rock Biotech (NASDAQ:BNR) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Burning Rock Biotech Limited is focused on applying next-generation sequencing technology to the field of precision oncology. Its business consists of NGS-based therapy selection tests for advanced-stage cancer patients as well as NGS-based early cancer detection. Burning Rock Biotech Limited is based in GUANGZHOU, China. “

Bridgewater Bancshares (NASDAQ:BWB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The company currently has a target price of $18.00 on the stock. According to Zacks, “Bridgewater Bancshares Inc. operates as a holding company for Bridgewater Bank which provides personal and commercial banking products and services to commercial real estate investors, small business entrepreneurs and high net worth individuals. The company offers checking, savings, money market savings, certificates of deposit accounts; bridge, home equity, temporary residential construction, land, construction, commercial real estate, long-term multi-family, working capital, letters of credit and executive lines of credit, options and debit and credit cards. Bridgewater Bancshares Inc. is headquartered in Bloomington, Minnesota.”

CBTX (NASDAQ:CBTX) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong buy rating. They currently have a price target of $32.00 on the stock. According to Zacks, “CBTX, Inc. is a bank holding company. It provides personal and commercial banking, home loans and investment services, as well as deposit, debit and credit card, cash management, cash and online banking services. CBTX, Inc. is based in Texas, USA. “

The Goldman Sachs Group, Inc. has begun hedging the shares of Cazoo Group (NYSE: CZOO). They issued a neutral rating on the title.

Roth Capital began covering the shares of Graphite One (OTC:GPHOF). Roth Capital has issued a buy rating on the stock.

1Life Healthcare (NASDAQ:ONEM) had its target price reduced by Piper Sandler from $20.00 to $15.00.

Mean (OTCMKTS: SFFYF) had its price target reduced by Credit Suisse Group AG from €50.00 ($53.19) to €40.00 ($42.55).

Oppenheimer Holdings Inc. initiated a hedge on the shares of Trevi Therapeutics (NASDAQ: TRVI). They issued an outperformance rating for the stock.

Petco Health and Wellness (NASDAQ:WOOF) had its target price lowered by Robert W. Baird from $25.00 to $21.00.



Get news and reviews for Absci Co Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Absci Co and related companies with MarketBeat.com’s free daily email newsletter.